Principal Financial Group Inc. Trims Holdings in AdaptHealth Corp. $AHCO

Principal Financial Group Inc. reduced its position in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 9.1% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,222,675 shares of the company’s stock after selling 223,700 shares during the quarter. Principal Financial Group Inc. owned about 1.64% of AdaptHealth worth $19,893,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently made changes to their positions in AHCO. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in AdaptHealth by 4.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 60,495 shares of the company’s stock valued at $656,000 after buying an additional 2,564 shares during the last quarter. Goldman Sachs Group Inc. boosted its holdings in shares of AdaptHealth by 32.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 571,232 shares of the company’s stock valued at $6,192,000 after acquiring an additional 139,828 shares during the last quarter. Woodline Partners LP acquired a new stake in AdaptHealth during the 1st quarter worth about $2,851,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of AdaptHealth by 18.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 233,780 shares of the company’s stock valued at $2,534,000 after purchasing an additional 35,879 shares in the last quarter. Finally, Janney Montgomery Scott LLC increased its stake in shares of AdaptHealth by 1.9% in the 2nd quarter. Janney Montgomery Scott LLC now owns 80,301 shares of the company’s stock valued at $757,000 after purchasing an additional 1,511 shares in the last quarter. 82.67% of the stock is owned by institutional investors.

AdaptHealth Stock Performance

Shares of NASDAQ AHCO opened at $10.65 on Monday. AdaptHealth Corp. has a 52 week low of $7.11 and a 52 week high of $11.63. The company has a debt-to-equity ratio of 1.09, a quick ratio of 0.86 and a current ratio of 1.08. The firm has a market cap of $1.44 billion, a price-to-earnings ratio of 19.36, a P/E/G ratio of 1.21 and a beta of 1.72. The business’s 50-day simple moving average is $10.14 and its 200-day simple moving average is $9.59.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Canaccord Genuity Group increased their price objective on shares of AdaptHealth from $14.00 to $15.00 and gave the company a “buy” rating in a report on Thursday, November 6th. Weiss Ratings raised AdaptHealth from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, January 30th. Wall Street Zen raised AdaptHealth from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 17th. Finally, Zacks Research raised AdaptHealth from a “strong sell” rating to a “hold” rating in a research report on Thursday, January 1st. Five equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $13.60.

Insider Buying and Selling

In other news, Director David Solomon Williams III sold 5,000 shares of the business’s stock in a transaction dated Thursday, December 4th. The stock was sold at an average price of $9.43, for a total transaction of $47,150.00. Following the completion of the transaction, the director directly owned 45,045 shares in the company, valued at approximately $424,774.35. The trade was a 9.99% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.55% of the stock is currently owned by insiders.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.